BACKGROUND: The relationship between marital status and prognosis of kidney cancer has not been explored in detail. In this study, we aimed to investigate the impact of marital status on survival outcomes in kidney cancer. METHODS: We used the Surveillance, Epidemiology and End Results (SEER) program to identify 112860 patients with kidney cancer diagnosed in 2004 through 2013. Kaplan-Meier methods and multivariable Cox regression models were used to analyze the influence of marital status on overall survival (OS) and cancer-specific survival (CSS). RESULTS: Married patients had better 5-year OS and CSS compared with patients who were divorced/separated, widowed, and single. After adjusting for known confounders, unmarried patients were at greater risk of overall and cancer-specific mortality, especially the widowed. Moreover, subgroup analysis showed that married still had better prognosis across different SEER stages, ages and sexes. CONCLUSIONS: Our study revealed that marriage is associated with better outcomes of both OS and CSS in kidney cancer patients.
BACKGROUND: The relationship between marital status and prognosis of kidney cancer has not been explored in detail. In this study, we aimed to investigate the impact of marital status on survival outcomes in kidney cancer. METHODS: We used the Surveillance, Epidemiology and End Results (SEER) program to identify 112860 patients with kidney cancer diagnosed in 2004 through 2013. Kaplan-Meier methods and multivariable Cox regression models were used to analyze the influence of marital status on overall survival (OS) and cancer-specific survival (CSS). RESULTS: Married patients had better 5-year OS and CSS compared with patients who were divorced/separated, widowed, and single. After adjusting for known confounders, unmarried patients were at greater risk of overall and cancer-specific mortality, especially the widowed. Moreover, subgroup analysis showed that married still had better prognosis across different SEER stages, ages and sexes. CONCLUSIONS: Our study revealed that marriage is associated with better outcomes of both OS and CSS in kidney cancer patients.
Marital status has been considered as an independent prognostic factor of survival in several types of cancer [1-4]. It is well known that social factors may influence the outcome of various diseases [5]. Marital status is regarded as an important social support factor and can greatly affect the patient’s emotions, life style, and financial status [6, 7]. Previous studies have shown that being married has a protective role in health and cancer survival compared with being unmarried [8, 9].Kidney cancer accounts for nearly 2% of all cancers, and there were an estimated 338,000 newly diagnosed cases and 143,000 deaths due to kidney cancer in 2012 [10]. In addition, 70% of new cases occurred in developed countries. Incidence and mortality rates of kidney cancer have been increasing in most countries over the past 30 years [11]. It is well-established that cigarette smoking, obesity and hypertension are risk factors for renal cell cancer [12]. However, little is known regarding the association between marital status and survival of patients with kidney cancer. In this study, we used data from the Surveillance, Epidemiology, and End Results (SEER) program to explore the impact of marital status on survival outcomes of kidney cancer patients.
RESULTS
Patient characteristics
We investigated a total of 112860 kidney cancer patients in the SEER database from 2004 to 2013, including 71549 (63.4%) male and 41311 (36.6%) female. Most patients are white (82.3%). According to marital status, 71328 (63.2%) were married at diagnosis, and 41352 (36.8%) were unmarried, including 11896 (10.5%) divorced/separated, 13160 (11.7%) widowed, and 16467 (14.6%) single. Compared with unmarried patients, the married patients were more likely to be diagnosed at an earlier stage and receive treatment. The widowed group had the highest percentage of women, the most elderly patients, and the lowest proportion of stage I and localized patients compared with the other groups and more were less likely to receive treatment. The baseline clinicopathological features are shown in Table 1.
Table 1
Baseline clinicopathological features of kidney cancer patients in SEER database
Characteristic
Total
Married
Divorced/Separated
Widowed
Single
P value
112860(100)
71328(63.2)
11896(10.5)
13160(11.7)
16476(14.6)
Sex
<0.001
Male
71549(63.4)
50344(70.6)
6697(56.3)
3973(30.2)
10535(63.9)
Female
41311(36.6)
20984(29.4)
5199(43.7)
9187(69.8)
5941(36.1)
Age
<0.001
<60
43627(38.7)
27709(38.8)
5307(44.6)
847(6.4)
9764(59.3)
60-70
31801(28.2)
21745(30.5)
3859(32.4)
2347(17.8)
3850(23.4)
70-80
24332(21.6)
15603(21.9)
2093(17.6)
4607(35.0)
2029(12.3)
>80
13100(11.6)
6271(8.8)
637(5.4)
5359(40.7)
833(5.1)
Race
<0.001
White
92909(82.3)
60549(84.9)
9474(79.6)
10975(83.4)
11911(72.3)
Black
13076(11.6)
6045(8.5)
1920(16.1)
1535(11.7)
3576(21.7)
American Indian/Alaska Native
952(0.8)
470(0.7)
125(1.1)
117(0.9)
240(1.5)
Asian/Pacific Islander
5324(4.7)
3853(5.4)
318(2.7)
505(3.8)
648(3.9)
Unknown
599(0.5)
411(0.6)
59(0.5)
28(0.2)
101(0.6)
Grade
<0.001
High/Moderate
51438(45.6)
33725(47.3)
5421(45.6)
4745(36.1)
7547(45.8)
Poor/Undifferentiation
29071(25.7)
19216(26.9)
3052(25.7)
2604(19.8)
4199(25.5)
Unknown
32351(28.7)
18387(25.8)
3423(28.8)
5811(44.2)
4730(28.7)
TNM
<0.001
I
63996(56.7)
41329(57.9)
6733(56.6)
6552(49.8)
9382(56.9)
II
9309(8.2)
5943(8.3)
986(8.3)
870(6.6)
1510(9.2)
III
14165(12.6)
9441(13.2)
1358(11.4)
1511(11.5)
1855(11.3)
IV
17801(15.8)
10524(14.8)
2044(17.2)
2552(19.4)
2681(16.3)
Unknown
7589(6.7)
4091(5.7)
775(6.5)
1675(12.7)
1048(6.4)
SEER Stage
<0.001
Localized
76192(67.5)
48989(68.7)
8025(67.5)
7877(59.9)
11301(68.6)
Regioned
16162(14.3)
10653(14.9)
1555(13.1)
1810(13.8)
2144(13.0)
Distant
16786(14.9)
9912(13.9)
1932(16.2)
2394(18.2)
2548(15.5)
Unstage
3720(3.3)
1774(2.5)
384(3.2)
1079(8.2)
483(2.9)
Therapy
<0.001
Surgery, radiation or both
94075(83.4)
62033(87.0)
9803(82.4)
8581(65.2)
13658(82.9)
No surgery, radiation
17823(15.8)
8845(12.4)
1980(16.6)
4354(33.1)
2644(16.0)
Unknown
962(0.9)
450(0.6)
113(0.9)
225(1.7)
174(1.1)
Impact of marital status on overall survival in the SEER database
We performed a Kaplan-Meier analysis to reveal the difference in overall survival (OS) according to marital status (log-rank test p<0.001) (Figure 1A). The 5-year OS rate was 69.5% in the married group, 63.2% in the divorced/separated group, 46.4% in the widowed group, and 67.2% in the single group. In addition to marital status, the results of the Kaplan-Meier analysis indicated that sex, age, race, grade, TNM stage, SEER stage, and therapy were significantly associated with OS in these patients. Cox regression was also used to adjust the variables mentioned above in the multivariate analysis, and marital status was found to be an independent prognostic factor for overall survival (married, reference; divorced/separated, HR=1.25, 95% CI 1.21-1.30, P<0.001; widowed, HR=1.25, 95% CI 1.21-1.29, P<0.001; single, HR=1.18, 95% CI 1.14-1.22, P<0.001) (Table 2).
Figure 1
Survival curves in kidney cancer patients according to marital status
(A) Overall survival: χ2 = 3122.46, P < 0.001. (B) Cancer specific survival:χ2 =1039.78, P < 0.001.
Table 2
Univariate and multivariate analysis for overall survival (OS) in kidney cancer patients
Variables
5-year OS
Univariate analysis
Multivariate analysis
Log rank Χ2
P value
HR
95% CI
P value
Sex
Male
64.70%
48.23
<0.001
Reference
Female
67.50%
0.89
0.87-0.91
<0.001
Age
<60
77.90%
12093.60
<0.001
Reference
60-70
68.70%
1.38
1.34-1.42
<0.001
70-80
58.60%
1.84
1.78-1.89
<0.001
>80
32.20%
2.61
2.52-2.71
<0.001
Race
White
65.60%
136.86
<0.001
Reference
Black
65.00%
1.07
1.04-1.11
<0.001
American Indian/Alaska Native
63.40%
0.97
0.87-1.09
0.587
Asian/Pacific Islander
68.50%
0.87
0.82-0.91
<0.001
Unknown
90.50%
0.31
0.23-0.42
<0.001
Grade
High/Moderate
83.10%
16886.37
<0.001
Reference
Poor/Undifferentiation
60.50%
1.70
1.65-1.75
<0.001
Unknown
42.00%
1.65
1.60-1.71
<0.001
TNM
I
83.10%
59552.13
<0.001
Reference
II
76.80%
1.43
1.36-1.50
<0.001
III
63.10%
0.83
0.75-0.93
0.001
IV
10.30%
2.04
1.81-2.30
<0.001
Unknown
42.90%
1.54
1.44-1.65
<0.001
SEER Stage
Localized
81.60%
61354.67
<0.001
Reference
Regioned
58.90%
2.73
2.46-3.03
<0.001
Distant
9.40%
4.27
3.79-4.81
<0.001
Unstage
25.90%
1.69
1.57-1.83
<0.001
Marital Status
Married
69.50%
3122.46
<0.001
Reference
Divorced/Separated
63.20%
1.25
1.21-1.30
<0.001
Widowed
46.40%
1.25
1.21-1.29
<0.001
Single
67.20%
1.18
1.14-1.22
<0.001
Therapy
Surgery, radiation or both
75.00%
39178.54
<0.001
Reference
No surgery, radiation
17.60%
2.49
2.41-2.56
<0.001
Unknown
30.40%
2.30
2.11-2.50
<0.001
Survival curves in kidney cancer patients according to marital status
(A) Overall survival: χ2 = 3122.46, P < 0.001. (B) Cancer specific survival:χ2 =1039.78, P < 0.001.
Impact of marital status on cancer-specific survival in the SEER database
Similarly, the survival curve showed that cancer-specific survival (CSS) among groups with different marital status was significant (log-rank test P<0.001) (Figure 1B). The 5-year CSS rates for the married group, the divorced/separated group, the widowed group and the single group were 82.1%, 77.8%, 70.4% and 80.1%, respectively. Among clinicopathological variables, sex, age, race, grade, TNM stage, SEER stage, therapy, and marital status were identified as risk factors for predicting CSS based on a Kaplan-Meier analysis. When a multivariate analysis with Cox regression was performed, marital status was confirmed to be an independent prognostic factor for kidney cancer prognosis (married, reference; divorced/separated, HR=1.20, 95% CI 1.15-1.26, P<0.001; widowed, HR=1.24, 95% CI 1.19-1.30, P<0.001; single, HR=1.14, 95% CI 1.09-1.19, P<0.001) (Table 3). In addition, age (≥ 60y), poor/undifferentiated, TNM stage, SEER stage, and no surgery and/or radiotherapy were associated with poorer CSS.
Table 3
Univariate and multivariate analysis for cancer specific survival (CSS) in kidney cancer patients
Variables
5-year CSS
Univariate analysis
Multivariate analysis
Log rank Χ2
P value
HR
95% CI
P value
Sex
Male
79.50%
13.26
<0.001
Reference
Female
81.00%
1.01
0.98-1.04
0.524
Age
<60
84.10%
2813.62
<0.001
Reference
60-70
81.20%
1.07
1.03-1.11
0.001
70-80
79.00%
1.14
1.09-1.19
<0.001
>80
63.30%
1.52
1.45-1.60
<0.001
Race
White
79.90%
79.39
<0.001
Reference
Black
81.60%
0.99
0.95-1.04
0.736
American Indian/Alaska Native
75.90%
1.00
0.87-1.16
0.970
Asian/Pacific Islander
78.90%
0.98
0.92-1.05
0.583
Unknown
93.60%
0.42
0.29-0.61
<0.001
Grade
High/Moderate
93.90%
12360.56
<0.001
Reference
Poor/Undifferentiation
72.30%
2.22
2.12-2.33
<0.001
Unknown
62.90%
2.12
2.02-2.23
<0.001
TNM
I
96.20%
65843.40
<0.001
Reference
II
87.90%
3.07
2.84-3.32
<0.001
III
76.90%
1.28
1.09-1.51
0.003
IV
17.20%
3.75
3.16-4.46
<0.001
Unknown
67.20%
2.57
2.28-2.90
<0.001
SEER Stage
Localized
94.90%
67229.90
<0.001
Reference
Regioned
73.20%
4.55
3.91-5.30
<0.001
Distant
15.90%
8.24
7.00-9.73
<0.001
Unstage
52.80%
2.77
2.44-3.14
<0.001
Marital Status
Married
82.10%
1039.78
<0.001
Reference
Divorced/Separated
77.80%
1.20
1.15-1.26
<0.001
Widowed
70.40%
1.24
1.19-1.30
<0.001
Single
80.10%
1.14
1.09-1.19
<0.001
Therapy
Surgery, radiation or both
86.00%
21427.48
<0.001
Reference
No surgery, radiation
42.00%
2.09
2.00-2.18
<0.001
Unknown
53.20%
2.25
2.01-2.51
<0.001
Subgroup analysis for evaluating the effect of marital status on CSS
We further explored the effects of marital status on CSS according to SEER stage (Figure 2 and Table 4). Marital status was still an independent prognostic factor at each stage, both in the univariate and multivariate analysis (P<0.001). Moreover, we observed some interesting findings. The widowed patients had poorer CSS in localized, regional and distant stages compared with the other groups, and being widowed was associated with a higher risk of mortality compared with being married in the localized stage (HR=1.51, 95% CI 1.36-1.67, P<0.001) and the distant stage (HR=1.22, 95% CI 1.08-1.37, P<0.001). The survival difference between the single and married groups was not apparent in the localized stage (P=0.679). Furthermore, a previous study showed that prognosis of kidney cancer was associated with increasing age [13]. Therefore, we further analyzed the survival rates and hazard according to age (Figure 3 and Table 5). Married patients always had better survival in each age group, which were consistent with the above results. However, no survival discrepancy was found among divorced/separated, widowed and single patients. We also performed a further stratified analysis by sex. Unmarried patients were shown to have poorer outcomes both in males and females, which was consistent with the above results (Figure 4 and Table 6).
Figure 2
Survival curves in kidney cancer patients on CSS according to marital status in different SEER stages
(A) Localized: χ2 = 554.76, P < 0.001; (B) regional: χ2 = 63.77, P < 0.001; (C) distant: χ2 = 198.85, P < 0.001.
Table 4
Univariate and multivariate analysis for evaluating marital status on CSS according to different SEER stage
Variables
5-year CSS
Univariate analysis
Multivariate analysis
Log rank Χ2
P value
HR
95% CI
P value
Localized
Marital status
554.76
<0.001
Married
95.60%
Reference
Divorced/Separated
94.50%
1.33
1.18-1.49
<0.001
Widowed
89.50%
1.51
1.36-1.67
<0.001
Single
95.60%
1.15
1.03-1.29
0.013
Regional
Marital status
63.77
<0.001
Married
75.00%
Reference
Divorced/Separated
70.50%
1.11
0.99-1.25
0.072
Widowed
65.70%
1.06
0.95-1.19
0.311
Single
71.60%
1.11
1.00-1.23
0.050
Distant
Marital status
198.85
<0.001
Married
17.70%
Reference
Divorced/Separated
13.90%
1.08
0.95-1.22
0.271
Widowed
12.60%
1.22
1.08-1.37
0.001
Single
13.10%
1.20
1.07-1.35
0.002
Figure 3
Survival curves in kidney cancer patients on CSS according to marital status in ages
(A) <60y: χ2 = 116.50, P < 0.001; (B) 60-70y: χ2 = 54.83, P < 0.001; (C) 70-80y: χ2 = 100.93, P < 0.001 (D) >80y: χ2 = 101.93, P < 0.001.
Table 5
Univariate and multivariate analysis for evaluating marital status on CSS according to different age
Variables
5-year CSS
Univariate analysis
Multivariate analysis
Log rank Χ2
P value
HR
95% CI
P value
<60y
Marital status
116.50
<0.001
Married
85.60%
Reference
Divorced/Separated
80.80%
1.18
1.09-1.27
<0.001
Widowed
81.80%
1.22
1.03-1.46
0.025
Single
82.10%
1.14
1.07-1.22
<0.001
60-70y
Marital status
54.83
<0.001
Married
82.20%
Reference
Divorced/Separated
78.30%
1.17
1.08-1.27
<0.001
Widowed
79.40%
1.21
1.08-1.34
0.001
Single
79.80%
1.13
1.03-1.23
0.006
70-80y
Marital status
100.93
<0.001
Married
80.90%
Reference
Divorced/Separated
73.90%
1.23
1.11-1.37
<0.001
Widowed
75.70%
1.24
1.14-1.35
<0.001
Single
77.00%
1.15
1.03-1.28
0.013
>80y
Marital status
101.93
<0.001
Married
67.70%
Reference
Divorced/Separated
59.30%
1.25
1.08-1.45
0.003
Widowed
58.80%
1.16
1.08-1.26
<0.001
Single
62.10%
1.07
0.93-1.23
0.328
Figure 4
Survival curves in kidney cancer patients on CSS according to marital status in different sexes
(A) Male: χ2 = 465.71, P < 0.001; (B) female: χ2 = 741.71, P < 0.001.
Table 6
Univariate and multivariate analysis for evaluating marital status on CSS according to sex
Variables
5-year CSS
Univariate analysis
Multivariate analysis
Log rank Χ2
P value
HR
95% CI
P value
Male
Marital status
465.71
<0.001
Married
81.20%
Reference
Divorced/Separated
75.40%
1.22
1.15-1.29
<0.001
Widowed
68.60%
1.28
1.20-1.38
<0.001
Single
77.90%
1.17
1.11-1.23
<0.001
Female
Marital status
741.71
<0.001
Married
84.30%
Reference
Divorced/Separated
80.90%
1.16
1.07-1.25
<0.001
Widowed
71.20%
1.14
1.07-1.22
<0.001
Single
83.80%
1.05
0.97-1.14
0.218
Survival curves in kidney cancer patients on CSS according to marital status in different SEER stages
(A) Localized: χ2 = 554.76, P < 0.001; (B) regional: χ2 = 63.77, P < 0.001; (C) distant: χ2 = 198.85, P < 0.001.
Survival curves in kidney cancer patients on CSS according to marital status in ages
(A) <60y: χ2 = 116.50, P < 0.001; (B) 60-70y: χ2 = 54.83, P < 0.001; (C) 70-80y: χ2 = 100.93, P < 0.001 (D) >80y: χ2 = 101.93, P < 0.001.
Survival curves in kidney cancer patients on CSS according to marital status in different sexes
(A) Male: χ2 = 465.71, P < 0.001; (B) female: χ2 = 741.71, P < 0.001.
DISCUSSION
In this study, we explored the influence of marriage on OS and CSS in kidney cancer patients based on the SEER program. Our study revealed that married patients had better survival outcomes than unmarried patients, including divorced or separated, widowed, and single patients. In addition, the widowed were at a higher risk of mortality compared with other unmarried groups. Both univariate and multivariate analysis indicated that marital status was an independent prognostic factor for predicting OS and CSS of kidney cancer. Moreover, the survival discrepancy between married and unmarried still existed across different sexes, ages and SEER stages.The results of our study showed that married patients can enjoy a survival advantage compared with unmarried patients, in agreement with previous studies on other types of cancer [1-4]. However, the mechanisms that drive this correlation are not yet clearly understood. We propose the following underlying mechanisms: Psychologically, depression is frequently observed in cancer patients [14]. Meta-analyses have shown that the depression in cancer patients can increase cancer mortality by 19% to 39% [15, 16]. A recent study showed that depression was significantly associated with a comparatively higher incidence of hospital admissions, emergency department visits, and health system utilization [17, 18]. Married patients have a lower risk of psychological distress, anxiety and depression, as their spouses can help share their emotional burden. Compared with married patients, unmarried patients showed not only greater levels of psychological distress but also lower levels of the fighting spirit and higher levels of helplessness [19]. Cancer survivors in the United States reported medication use for anxiety and depression at rates nearly two times those reported by the general public, and unmarried are more likely to use medication [20]. In addition, psychological stress may cause poorer adherence to treatment [21].Physiologically, marriage may have direct influences on cardiovascular, endocrine, immune, neurosensory, and other physiological functions [22]. Endocrine hormones, such as cortisol and catecholamine, can promote tumor growth and metastasis [23]. Married individuals had lower cortisol levels than their never married and previously married counterparts. Cortisol could be regarded as one candidate mechanism accounting for the association of marital status and health [24]. Additionally, the hypothalamus-pituitary-adrenal axis may also have an effect on the immune system, leading to poorer survival [25, 26].Another widely accepted explanation of why married patients have better prognosis of cancer and other diseases is that married patients have better social-economic support. It has been reported that married persons are more likely to have better access to medical care and more financial support than unmarried persons [8]. In addition, married couples may have wider health insurance coverage [27]. Thus, spouses might contribute to earlier disease detection [8]. These factors could partly explain why married patients corresponded to a higher percentage of earlier stage cancer in our study. Married patients also have better adherence with prescribed treatments. We found that unmarried, especially widowed, had a lower percentage of surgery and radiotherapy, which could be attributed to the survival difference between the married and unmarried patients. In addition, lifestyles, such as diet habit and behaviors, may also be influenced by marriage [28]. For example, it is well accepted that smoking increases the risk of kidney cancer. Studies show that living without a spouse increases daily smoking rates [29]. Moreover, marriage is associated with an increased probability of cessation for men [30].Nevertheless, some limitations should be noted. First, the SEER database only provides marital status at the time of diagnosis, which may change after diagnosis. In addition, the quality of the marriage could not be evaluated in the follow-up. SEER also does not record cohabitation status, patients cohabitating with their partners may be categorized as unmarried in the SEER database. Second, we had no direct information on socioeconomic factors, such as educational information, income status, insurance status, and lifestyle (such as smoking and alcohol use), which are not recorded in the SEER database. Third, the SEER database is unable to provide other important survival factors, such as chemotherapy, details of surgery, and other types of therapy. Lastly, as a retrospective study, we could not avoid various forms of bias.Despite these potential limitations, our study revealed that married kidney cancer patients had survival advantages, while unmarried patients were at higher risk of overall and cancer-specific mortality. We supposed that psychological, physiological and social-economic factors may contribute more to survival outcomes among married patients. Physicians should realize this significant survival difference according to marital status. More social support services and medical interventions should be provided for unmarried patients. Furthermore, future studies should focus on the mechanisms among marital functioning, physiology, and health and on genetic and other variable explanations for marriage-related health outcomes. Additional studies of objective social behavior after changes in marital status are also warranted.
MATERIALS AND METHODS
Data source and patient selection
This study used data from the SEER database released in March 2017, which covered approximately 28% of the United States population. By using SEER-stat software (version 8.3.4), we searched the database for patients diagnosed between 2004 and 2013 with kidney cancer. Patients aged 18 or older at the time of diagnosis with kidney cancer (International Classification of Diseases for Oncology, Third Edition [ICD-O-3], code C64.9) were included for analysis. Patients were excluded if they had unknown marital status, unknown cause of death or unknown survival time. A total of 112860 patients were included in the cohort. This study was based on public data from the SEER database; we obtained permission to access research data files with the reference number 14920-Nov2015. Because this study did not include the use of human subjects or personal identifying information, this study did not require informed consent.
Study variables
Variables extracted from the SEER database included marital status, sex, age at diagnosis, race, histological grade, TNM stage, SEER stage, and selection of therapy (surgery/radiotherapy). Marital status is coded as married, divorced or separated, widowed, and single. Age at diagnosis was divided into four groups: <60 years, 60-70 years, 70-80 years, and ≥80 years. Race was classified as white, black, American Indian/Alaska Native, Asian/Pacific Islander, or unknown. Histological grade was classified as well/moderately differentiated, poorly differentiated/undifferentiated, or unknown. SEER stage was categorized as localized, regional, distant, or unknown. Selection of therapy was divided into three groups: surgery or radiation or both, no surgery or radiation, and unknown.
Outcomes
The primary outcomes were OS and CSS. OS was calculated from the date of diagnosis to the date of death from any cause. Patients who were alive on the date of last contact or at the follow-up cut-off date were censored. CSS was defined as the time from diagnosis to the date of death due to kidney cancer. Death caused by kidney cancer was considered an event. Patients who died from other causes or who were still alive at the time of the last follow-up were treated as censored. The follow-up cut-off date was December 31, 2013, according to the SEER database.
Statistical analysis
The association between marital status and clinicopathological features was assessed by the chi-square (χ2) test. Survival curves were generated by the Kaplan-Meier method; differences between the curves were analyzed by using the Log-rank test. Multivariable Cox proportional hazards regression models were used to assess potential risk factors for survival outcomes. All statistical analyses were performed using SPSS for Windows, version 19 (SPSS Inc., Chicago, IL, USA). All P values were 2-sided, and P<0.05 was considered statistical significance.
Authors: Giuseppe Rosiello; Sophie Knipper; Carlotta Palumbo; Cristina Dzyuba-Negrean; Angela Pecoraro; Elio Mazzone; Francesco A Mistretta; Zhe Tian; Umberto Capitanio; Francesco Montorsi; Shahrokh F Shariat; Fred Saad; Alberto Briganti; Pierre I Karakiewicz Journal: Int Urol Nephrol Date: 2019-08-29 Impact factor: 2.370
Authors: Yulian Mytsyk; Serhiy Pasichnyk; Ihor Dutka; Ihor Dats; Dmytro Vorobets; Michał Skrzypczyk; Yerzhan Uteuliyev; Andrea Botikova; Katarina Gazdikova; Peter Kubatka; Peter Urdzik; Peter Kruzliak Journal: Clin Exp Med Date: 2020-02-05 Impact factor: 3.984